EUCTR2021-006108-34-NL招募中1 期
Trial Examining Methods for Antidepressant Discontinuation - TEMPO
AmsterdamUMC (location VUmc)0 个研究点目标入组 200 人开始时间: 2022年8月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •To be eligible to participate in this study, a subject must meet all of the following criteria:
- •Age 18-75 years
- •Stable 6-month remission of MDD
- •Confirmed >6 months use of PAR (20-50mg) or VLX (75-375mg)
- •Previous MDD episode and current remission confirmed with semi-structured psychiatric interview (MINI).
- •Willing and able to provide informed consent and follow the procedures necessary to participate in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 200
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 40
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •Psychotic/bipolar disorder
- •Severe drug/alcohol addiction that warrants clinical attention
- •Insufficient mastery of Dutch language.
研究者
相似试验
招募中
不适用
Trial Examining Methods for Antidepressant Discontinuatiodepressionmajor depressive disorder10027946NL-OMON55952Amsterdam UMC200
招募中
4 期
Trial Examining Methods for Antidepressant DiscontinuatioNL-OMON29528AmsterdamUMC200
已完成
不适用
Exploratory trial of antidepressant therapy for dizzinessSigns and Symptoms: DizzinessSigns and SymptomsDizzinessISRCTN80847419Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)64
已完成
2 期
?The effect of depressor septi nasi cutting in nasolabial angle and nasal tip formTip rhinoplasty.Other plastic surgery for unacceptable cosmetic appearanceIRCT201106086745N1Investigator80
进行中(未招募)
1 期
Pillot randomised controlled trial of antidepressant switching for treatmetn-refractory depression in primary care - SWITCh studyDepressionEUCTR2004-004029-87-GBInstitute of Psychiatry100
